Cargando…

Renal Function and Body Mass Index Contribute to Serum Neurofilament Light Chain Levels in Elderly Patients With Atrial Fibrillation

OBJECTIVE: Serum neurofilament light chain (sNfL) is increasingly used as a neuroaxonal injury biomarker in the elderly. Besides age, little is known about how other physiological factors like renal function and body mass index (BMI) alter its levels. Here, we investigated the association of estimat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polymeris, Alexandros A., Helfenstein, Fabrice, Benkert, Pascal, Aeschbacher, Stefanie, Leppert, David, Coslovsky, Michael, Willemse, Eline, Schaedelin, Sabine, Blum, Manuel R., Rodondi, Nicolas, Reichlin, Tobias, Moschovitis, Giorgio, Wuerfel, Jens, De Marchis, Gian Marco, Engelter, Stefan T., Lyrer, Philippe A., Conen, David, Kühne, Michael, Osswald, Stefan, Bonati, Leo H., Kuhle, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047720/ https://www.ncbi.nlm.nih.gov/pubmed/35495025 http://dx.doi.org/10.3389/fnins.2022.819010

Ejemplares similares

Serum neurofilament light in atrial fibrillation: clinical, neuroimaging and cognitive correlates
por: Polymeris, Alexandros A, et al.
Publicado: (2020)

Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation
por: De Marchis, Gian Marco, et al.
Publicado: (2023)

Right Hemispheric Predominance of Brain Infarcts in Atrial Fibrillation: A Lesion Mapping Analysis
por: Altermatt, Anna, et al.
Publicado: (2022)

Sex differences of vascular brain lesions in patients with atrial fibrillation
por: Ceylan, Selinda, et al.
Publicado: (2022)

Cardiac autonomic function and cognitive performance in patients with atrial fibrillation
por: Hämmerle, Peter, et al.
Publicado: (2021)

Blood Pressure and Brain Lesions in Patients With Atrial Fibrillation
por: Aeschbacher, Stefanie, et al.
Publicado: (2020)

Development of an age‐adjusted model for blood neurofilament light chain
por: Harp, Christopher, et al.
Publicado: (2022)

Serum Neurofilament Light Chain: A Marker of Nervous System Damage in Myopathies
por: Saak, Annika, et al.
Publicado: (2021)

Alcohol consumption and risk of cardiovascular outcomes and bleeding in patients with established atrial fibrillation
por: Reddiess, Philipp, et al.
Publicado: (2021)

Brain lesions and cognitive decline in patients with atrial fibrillation
por: Hennings, E, et al.
Publicado: (2023)

Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis
por: Reinert, Marie-Christine, et al.
Publicado: (2020)

Blood neurofilament light chain at the doorstep of clinical application
por: Leppert, David, et al.
Publicado: (2019)

Association of the CHA(2)D(S(2))-VASc Score and Its Components With Overt and Silent Ischemic Brain Lesions in Patients With Atrial Fibrillation
por: Steiner, Fabienne, et al.
Publicado: (2021)

Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillation
por: Girod, Marc, et al.
Publicado: (2022)

Protocol for MAAESTRO: Electronic Monitoring and Improvement of Adherence to Direct Oral Anticoagulant Treatment—A Randomized Crossover Study of an Educational and Reminder-Based Intervention in Ischemic STROke Patients Under Polypharmacy
por: Polymeris, Alexandros A., et al.
Publicado: (2018)

A Method to Combine Neurofilament Light Measurements From Blood Serum and Plasma in Clinical and Population-Based Studies
por: Rübsamen, Nicole, et al.
Publicado: (2022)

Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters
por: Hermesdorf, Marco, et al.
Publicado: (2022)

Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort study
por: Moutzouri, Elisavet, et al.
Publicado: (2023)

Association of Heart Rate Variability With Silent Brain Infarcts in Patients With Atrial Fibrillation
por: Hämmerle, Peter, et al.
Publicado: (2021)

Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation
por: Witassek, Fabienne, et al.
Publicado: (2019)

Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage
por: Schaub, Fabian, et al.
Publicado: (2021)

The Omega-3 Fatty Acid Eicosapentaenoic Acid (EPA) Correlates Inversely with Ischemic Brain Infarcts in Patients with Atrial Fibrillation
por: Reiner, Martin F., et al.
Publicado: (2021)

Factors influencing serum neurofilament light chain levels in normal aging
por: Koini, Marisa, et al.
Publicado: (2021)

Impact of the COVID-19 lockdown on the adherence of stroke patients to direct oral anticoagulants: a secondary analysis from the MAAESTRO study
por: Dietrich, Fine, et al.
Publicado: (2021)

Serum Neurofilament Light Chain Is Associated with Incident Lacunes in Progressive Cerebral Small Vessel Disease
por: Peters, Nils, et al.
Publicado: (2020)

Antibodies to neurofilament light as potential biomarkers in multiple sclerosis
por: Puentes, Fabiola, et al.
Publicado: (2021)

Serum neurofilament light levels in normal aging and their association with morphologic brain changes
por: Khalil, Michael, et al.
Publicado: (2020)

Mid-term changes in cognitive functions in patients with atrial fibrillation: a longitudinal analysis of the Swiss-AF cohort
por: Wueest, Alexandra S., et al.
Publicado: (2023)

Monitoring of radiologic disease activity by serum neurofilaments in MS
por: Uher, Tomas, et al.
Publicado: (2020)

Biomarkers, Clinical Variables, and the CHA(2)DS(2)-VASc Score to Detect Silent Brain Infarcts in Atrial Fibrillation Patients
por: Krisai, Philipp, et al.
Publicado: (2021)

Association of Diabetes With Atrial Fibrillation Phenotype and Cardiac and Neurological Comorbidities: Insights From the Swiss‐AF Study
por: Bano, Arjola, et al.
Publicado: (2021)

A factor score reflecting cognitive functioning in patients from the Swiss Atrial Fibrillation Cohort Study (Swiss-AF)
por: Springer, Anne, et al.
Publicado: (2020)

Omega‐3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial Fibrillation
por: Baumgartner, Philipp, et al.
Publicado: (2023)

Long-term risk of adverse outcomes according to atrial fibrillation type
por: Blum, Steffen, et al.
Publicado: (2022)

Acute Ischemic Stroke in Nonconvulsive Status Epilepticus–Underestimated? Results from an Eight-Year Cohort Study
por: Traenka, Christopher, et al.
Publicado: (2017)

Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population—an analysis from the MEMO study
por: Rübsamen, Nicole, et al.
Publicado: (2021)

Biomarkers of Inflammation and Risk of Hospitalization for Heart Failure in Patients With Atrial Fibrillation
por: Benz, Alexander P., et al.
Publicado: (2021)

Neurocognitive function in patients with atrial fibrillation undergoing pulmonary vein isolation
por: Zwimpfer, Leon, et al.
Publicado: (2022)

Evidence of polygenic regulation of the physiological presence of neurofilament light chain in human serum
por: Herrera-Rivero, Marisol, et al.
Publicado: (2023)

Association of cardiac rhythm with cognitive performance in atrial fibrillation patients
por: Mosher, L, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_or7bpktsqnmimm328u5l2onvp1